| INTRODUCTION
Acute lower respiratory infections (ALRI) include conditions such as bronchiolitis, pneumonia and influenza. The true burden of disease is difficult to calculate with estimates heavily influenced by identification methods. Globally, an estimated 10 per 1000 children aged less than 5 years were hospitalized for ALRI in 2010 in the developed world. 1 Using linked administrative data, we estimated that in Western Australia (WA) the true rate was significantly higher; approximately 45 per 1000 children were hospitalized for ALRI before their second birthday, with a much higher burden among Aboriginal and Torres
Strait Islander children (hereafter referred to as Aboriginal). 2 Viruses associated with ALRI include influenza viruses, respiratory syncytial virus (RSV) and human metapneumovirus (hMPV). Current vaccines targeting ALRI viral pathogens are limited to influenza; however, multiple RSV vaccine candidates are in clinical trials. 3 Accurate pathogen-specific estimates are paramount before planning or evaluating prevention programmes.
At present, most retrospective studies using hospital admission data to investigate the aetiology of ALRI begin by selecting children with an International Classification of Disease (ICD) discharge code for ALRI. ICD codes alone are insufficient to provide accurate estimates of the true burden of respiratory pathogens because they are poorly sensitive, 4 with limited use of pathogen-specific codes. Furthermore, data are often from selected hospitals and may not be representative of the wider population. One method for more accurate calculations of the pathogen-specific burden for a whole population is record linkage.
Record linkage combines data from multiple sources relating to the same person. 5 Access to large, population-level data sets at relatively low cost is one advantage of record linkage over prospective studies. 6 We have shown that record linkage is a feasible and valid method for describing the pathogen-specific aetiology of ALRI. 7, 8 It is also useful for identifying conditions and populations where current databases underestimate the burden of disease.
We first sought to more accurately describe the pathogen-specific burden of respiratory viruses (specifically by age-specific rates and clinical diagnoses) identified in a cohort of WA-born children hospitalized between 2000 and 2012. As significant portions of hospitalized children are not tested for respiratory viruses, their viral burden is probably underestimated. Therefore, we also aimed to characterize those who were not tested so that statistical modelling could be used to assign viruses to those who were not tested, based on demographic and admission factors. 
| PATIENTS AND METHODS

| Setting and data sources
| Hospital data
As PathWest data were only available from 2000, we restricted hospital records to those with an admission date between January 2000 and December 2012. Only hospital records with an admission and discharge date during the study period were included (hereafter referred to as hospital admissions). Admissions on or after the date of death were considered post-mortem admissions and excluded.
Clinical diagnosis was classified using a hierarchy of ALRI, upper respiratory tract infections (URTI), or other, with priority given to ALRI.
Admissions were classified as ALRI if they had a principal or codiagnosis ICD-10-AM (ICD 10th revision, Australian Modification) code for pneumonia, bronchiolitis, influenza, unspecified ALRI, bronchitis or whooping cough (codes listed in Table S1 ). 10 Admissions with a principal or codiagnosis of URTI, such as otitis media and sinusitis, were classified as URTI (Table S1) . 11 All other admissions were classified as "other" and further subdivided based on principal diagnosis codes (Table S1 ).
Interhospital transfers were defined as multiple adjacent records of the same person where either (i) the admission date was identical to the discharge date of the prior record; or (ii) the admission date occurred before the discharge date of the prior record; or (iii) both admission and discharge dates fell within the time span of the prior record. These records were collapsed and considered a single admis- (Table S1 ). Admissions where both picornavirus and rhinovirus were detected were coded as rhinovirus, whereas if only an unspecified picornavirus was identified, it was coded as a picornavirus admission.
| Laboratory data
Laboratory records were merged with a hospital record if respiratory specimens were collected 48 hours before or after the admission date. If the same person had multiple admissions for different reasons within 48 hours, laboratory records were linked to the ALRI admission.
If the same person had multiple admissions for the same reason within 48 hours, laboratory records were linked to the admission closest to the date of specimen collection.
| Statistical analysis
After merging hospital and laboratory records, we compared the 
| RESULTS
Of 469 Of all laboratory-confirmed admissions, 47.8% had an ALRI diagnosis (n = 20 874; Figure 1 ). Over 70% of laboratory-confirmed admissions with an ALRI diagnosis concerned children aged less than 2 years old at admission (Table S2 ). The majority of these children were diagnosed with bronchiolitis (n = 11 413) or pneumonia (n = 4484). Of the laboratory-confirmed admissions with an URTI diagnosis, acute upper respiratory infection (n = 5558) was the most common diagnosis.
We noted that 38.4% of laboratory-confirmed admissions did not have an ALRI or URTI diagnosis ( Figure 1 ). These were commonly coded as viral infection of an unspecified site (n = 3338, 19.9%); other infections (n = 1786, 10.7%); asthma (n = 1595, 9.5%); or breathing abnormalities (n = 1228, 7.3%; Table 1 ). Approximately 12.5% of these admissions related to children aged 5 years or more at admission and 12.3% of these admissions included a stay in ICU (Table S2 ).
| Pathogen-specific burden of respiratory viruses
Overall, 40.7% (n = 17 747) of laboratory-confirmed admissions had at least one respiratory virus detected. Virus detection was highest among those diagnosed with ALRI (n = 12 192, 58.4%) and among children aged 6-23 months at admission (n = 7087, 39.9%).
Approximately 20.6% (n = 3651) of laboratory-confirmed admissions with at least one virus detected did not have an ALRI or URTI diagnosis (Table 1) . RSV was the most commonly detected virus, with an incidence rate that was four times higher (95% CI=3.8-4.1) than the next most common virus (Table 1 ). RSV incidence rates were highest among children under 6 months of age ( Figure 2A ) and among those diagnosed with bronchiolitis (Table 1) .
Unspeciated picornavirus, RSV, parainfluenza and rhinovirus had similar incidence rates among children with other diagnoses (Table 1) .
Rates of unspeciated picornavirus were highest among infants aged less than 1 month ( Figure 2B ). On the other hand, rates of parainfluenza and influenza virus peaked in children aged 1-5 months. Among all laboratory-confirmed admissions with parainfluenza detected, parainfluenza type three was the most common (n = 1548, 69. 
| Exploring under-ascertainment of respiratory viruses
Univariable analyses suggested that age at admission, diagnosis, length of stay, hospital type and mechanical ventilation were strongly associated with failure to test for respiratory viruses ( Table 2 ). These variables remained significant after adjusting for all other variables in the multivariable model.
Children over 5 years of age and those without an ALRI diagnosis had at least fourfold greater odds of not being tested (Table 2) .
Furthermore, admissions to non-tertiary hospitals had at least three-
fold odds of not being tested than admissions to tertiary hospitals.
When restricted to admissions with an ALRI diagnosis, results were similar for all variables except ICU admission and interhospital transfers (Table S3) . Children admitted to regular wards with an ALRI diagnosis had 0.71 times the odds of failing to test for respiratory viruses compared to those admitted to ICU (Table S3) . Likewise, admissions following interhospital transfers had lower odds of not receiving a test than those who were transferred (Table S3 ).
| DISCUSSION
As ICD codes alone can underestimate the burden of respiratory viruses, we used linked laboratory and hospital data to determine more accurate estimates of the virus-specific burden of ALRI among hospitalized children. We determined that the overall incidence rate of RSV was 247 per 100 000 child-years, with a similar rate among Approximately 38% of all laboratory-confirmed admissions were not coded as ALRI or URTI, with 22% of these admissions testing positive for at least one respiratory virus. These do not appear to be solely attributable to asymptomatic virus identification as many of these viruses were infrequently detected in asymptomatic children. 16 Moreover, these laboratory-confirmed admissions were mostly unspecified diagnosis codes (eg, viral infections of unspecified site) or non-specific clinical symptoms (eg, breathing abnormalities). This highlights the limitations of using ICD codes alone when calculating disease estimates, as documented elsewhere. 4, 17, 18 Previous studies also support the notion that coding algorithms, particularly for less welldefined diseases, are needed for accurate disease estimates. 19 These are crucial to policy development and are often used as baseline data when evaluating the impact of said policies. Our findings further highlight the need to look beyond ICD codes when estimating infectious disease burden and the impact of vaccination programs.
While there were many laboratory-confirmed admissions without a respiratory code, over half of all ALRI admissions were not tested for respiratory viruses, implying that the burden of specific viruses is still underestimated. Without the capacity to directly influence testing patterns and because it is economically unfeasible to impose universal testing, one possibility to address this issue is by statistical modelling.
By characterizing those testing positive for particular viruses, we could extrapolate virus "detection" to those with similar characteristics but not tested. This method was used on similar data in England, 20 and a future study using these data is planned.
We noted that admissions to private metropolitan hospitals had five times greater odds of failing to test compared to tertiary hospitals.
As a limited number of private hospitals do not routinely use PathWest laboratories, it is difficult to differentiate testing practices from specimen referral pathways. Despite this, the frequency of virus detection in private metropolitan hospitals in this data set was comparable to tertiary hospitals, as was the distribution of viruses (data not shown).
Inclusion of laboratory data from private pathology providers would thus further enhance our disease estimates.
Previous work validating linked laboratory data in WA suggested that approximately 75% of ALRI-related admissions should have an associated laboratory record for respiratory pathogen testing. 8 Notwithstanding the exclusion of bacterial pathogens and commonly associated tests (eg, blood culture), the proportion of We were unable to investigate the role of comorbidities (eg, immunosuppression) and antiviral use on testing practices and the frequency of virus detection. We also could not examine the emerging role of rhinovirus in severe respiratory infections 21 as picornaviruses were not routinely speciated. While we focussed on respiratory viruses, competition and interactions with bacterial pathogens are likely to influence incidence rates of individual viruses investigated here.
Inclusion of data on bacterial pathogens is the next step in assessing the burden of all respiratory pathogens.
| CONCLUSION
Despite these limitations, this is one of the few studies, to our knowledge, to quantify the population-level burden of respiratory viruses in children, irrespective of diagnosis. It is also the first to use individual, rather than aggregated, person-time-at-risk data to more accurately estimate the rate of respiratory virus infection. This has enabled reporting of pathogen-specific incidence rates of these viruses, the majority of which are not notifiable. Access to data on all admissions for a whole population, in addition to both positive and negative test results, is a major strength of this study. Using these data, we have shown that respiratory viruses are pervasive and their prevention could reduce the burden of respiratory and non-respiratory hospitalizations. These data provide a framework for further, in-depth studies to enhance current and future preventative strategies. We plan to use these data to investigate temporal trends and risk factors for specific viruses and their combinations in the context of changes in testing patterns.
